Focusing on prevention approaches in COPD (including inhaled and non-inhaled advanced therapies, use of eosinophil biomarkers etc), approaches to distinguishing viral from bacterial infections (with associated implications for antibiotic stewardship) and an update on current understanding and approaches to managing long COVID syndromes.
Learning objectives:
Dr Aran Singanayagam Background
Dr Aran Singanayagam completed his medical training at the University of Edinburgh in 2005 achieving distinction in his final examinations alongside a first-class intercalated BSc in physiology. He trained as a respiratory doctor within north-west London, primarily at St Mary’s, Royal Brompton and Harefield hospitals.
Our consultant cardiologist, Dr Miles Dalby, outlines the management of valvular heart disease, highlighting the transcatheter therapies available.
This talk explores a pioneering new technique, endobronchial optical coherence tomography for minimally invasive, volumetric microscopic imaging in interstitial lung disease.
Dr Wala Mattar’s talk focuses on diagnosis and immediate and long term management of acute coronary syndrome.
This talk provides an overview of the management and prognosis of rare lung diseases, looking at the differential diagnosis in detail.
This talk provides an overview of TAVI, delving into what the future holds and what has been accomplished to date.
Our consultant respiratory physician, Dr Vasilis Kouranos, provides an overview on how to treat and monitor patients presenting sarcoidosis.
Professor Sébastien Gagneux provides an overview of tuberculosis (TB), delving into the reasons on how TB becomes resistant in individuals.
Professor Andrew Menzies-Gow discusses maintenance of oral corticosteroids for severe eosinophilic asthma, overviewing the PONENTE study.
Our consultant cardiothoracic radiologist, Dr Tarun Mittal looks at appropriate uses of imaging in patients with stable chest pain in cardiac CT, stress imaging, etc as per NICE recommendations.
This talk discusses pulmonary hypertension in advanced lung diseases, focusing on the evolving treatment options in continual clinical trials.
This talk provides an overview on ARDS, ECMO and COVID-19 and the effects of severe respiratory failure on patient outcomes.